Literature DB >> 8994246

Down's syndrome screening marker levels following assisted reproduction.

G Barkai1, B Goldman, L Ries, R Chaki, J Dor, H Cuckle.   

Abstract

Maternal serum alpha-fetoprotein (AFP), human chorionic gonadotrophin (hCG), and unconjugated oestriol (uE3) levels were examined in 1632 women who had ovulation induction and 327 who had in vitro fertilization. There was a highly statistically significant increase in hCG and reduction in uE3 among those with ovulation induction. The median levels were respectively 1.09 and 0.92 multiples of the normal gestation-specific median (MOM) based on a total of 34582 women. Ovulation induction appeared to have no material effect on the median AFP level but this masked a significant increase when treatment was with Clomiphene (1.05 MOM) and a significant decrease when Pergonal was used (0.93 MOM). There was a highly statistically significant reduction in uE3 among women having in vitro fertilization with a median level of 0.92 MOM. Those fertilized with a donor egg (21) had significantly higher AFP and uE3 levels than when their own egg was used. Our results were confounded by differences in gravidity, but formally allowing for this factor did not materially change the findings. None of the observed effects is great enough to warrant routine adjustment of marker levels to allow for them. Moreover, women with positive Down's syndrome screening results can be reassured that this is unlikely to be due to them having had assisted reproduction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8994246     DOI: 10.1002/(SICI)1097-0223(199612)16:12<1111::AID-PD998>3.0.CO;2-X

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  8 in total

1.  Triple-test screening in in vitro fertilization pregnancies.

Authors:  I Bar-Hava; M Yitzhak; H Krissi; M Shohat; J Shalev; B Czitron; Z Ben-Rafael; R Orvieto
Journal:  J Assist Reprod Genet       Date:  2001-04       Impact factor: 3.412

2.  First-trimester screening for Down syndrome in singleton pregnancies achieved by intrauterine insemination.

Authors:  Tsung-Hsuan Lai; Su-Chee Chen; Ming-Song Tsai; Fa-Kung Lee; Chi-Feng Wei
Journal:  J Assist Reprod Genet       Date:  2003-08       Impact factor: 3.412

3.  Quadruple test parameters in art pregnancies.

Authors:  Nilgün Güdücü; Uzay Görmüş; Ebru İlhan Güner; Omer Güzel; Zehra Neşe Kavak
Journal:  Int J Clin Exp Med       Date:  2014-08-15

Review 4.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 5.  First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 6.  Second trimester serum tests for Down's Syndrome screening.

Authors:  S Kate Alldred; Jonathan J Deeks; Boliang Guo; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

Review 7.  First trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-11-30

Review 8.  Urine tests for Down's syndrome screening.

Authors:  S Kate Alldred; Boliang Guo; Yemisi Takwoingi; Mary Pennant; Susanna Wisniewski; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.